Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
Cancer Immunology, Immunotherapy · 2024
DOI: 10.1007/s00262-024-03855-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Jiaying Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou Dis…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Central Nervous System Neoplasms, Immunotherapy, Adoptive, Transplantation, Autologous. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, Hubei, China.
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, Hubei, China. doctormeng@163.com.
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, Hubei, China. zhuxiaojian@hust.edu.cn.
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, Hubei, China. yixiao@tjh.tjmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, J., Liu, W., Cao, Y., Yang, Y., Shang, Z., Zhou, M., Zhang, Y., Meng, F., Zhu, X., & Xiao, Y. (2024). Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03855-7
Vancouver
Wu J, Liu W, Cao Y, Yang Y, Shang Z, Zhou M, et al. Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03855-7
BibTeX
@article{Wu2024,
author = {Wu, Jiaying and Liu, Wanying and Cao, Yang and Yang, Yang and Shang, Zhen and Zhou, Mi and Zhang, Yicheng and Meng, Fankai and Zhu, Xiaojian and Xiao, Yi},
title = {Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma},
journal = {Cancer Immunology, Immunotherapy},
year = {2024},
doi = {10.1007/s00262-024-03855-7}
}
EUVIMED